Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy

This clinical trial studies whether a new multi-layer perinatal tissue allograft, MLG-Complete (Trademark), can be used to improve complications after nerve-sparing robot-assisted radical prostatectomy (RARP) in patients with prostate cancer that has not spread to other parts of the body (localized). Two major complications that can happen after complete surgical removal of the prostate (radical prostatectomy) include erectile dysfunction and urinary incontinence, both of which greatly affect a patient's quality of life and social well-being. The goal of nerve-sparing radical prostatectomy is

Trial Details

NCT ID
NCT06940271
Phase
NA
Sponsor
Mayo Clinic
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Allografting
  • Survey Administration
Locations (sample)
  • Jacksonville, Florida, United States|30.33218,-81.65565

Key Eligibility Criteria

  • Male subjects with age ≥ 45
  • Primary diagnosis of prostate cancer selected for surgical intervention (radical prostatectomy)
  • Primary diagnosis of organ confined (i.e. localized) untreated prostate cancer
  • Planned elective radical prostatectomy with bilateral nerve sparing technique

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →